Evidence map›Paper›PMID 22920457›Full record

ArticleBiochemistry2012

A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition.

Andrew M Lipchik, Renee L Killins, Robert L Geahlen, Laurie L Parker

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrew M LipchikDepartment of Medicinal Chemistry and Molecular Pharmacology and Purdue Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
Renee L Killins
Robert L Geahlen
Laurie L Parker
Center for Cancer Research · US

Funding

TYROSINE PROTEIN KINASES AND LYMPHOCYTE ACTIVATIONR01CA037372 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI GEAHLEN, ROBERT L · 1985 to 2011
$3.5M
Tyrosine Kinases and Lymphocyte ActivationR01AI098132 · NIAID · PURDUE UNIVERSITY · PI GEAHLEN, ROBERT L · 2012 to 2016
$1.6M
Interdisciplinary Cancer Prevention Research Internship ProgramR25CA128770 · NCI · PURDUE UNIVERSITY · PI TEEGARDEN, DOROTHY · 2008 to 2012
$1.5M
Biosensor design for detection and analysis of complex signal patterns in cancerR00CA127161 · NCI · PURDUE UNIVERSITY · PI PARKER, LAURIE L. · 2010 to 2012
$785k
Biosensor design for detection and analysis of complex signal patterns in cancerK99CA127161 · NCI · PURDUE UNIVERSITY · PI PARKER, LAURIE L. · 2008 to 2009
$279k
NCI NIH HHS CA037372NCI NIH HHS CA127161NCI NIH HHS K99 CA127161NCI NIH HHS R00 CA127161NCI NIH HHS R01 CA037372NCI NIH HHS R25 CA128770NCI NIH HHS R25CA128770NIAID NIH HHS AI098132NIAID NIH HHS R01 AI098132
6 · The paper itself

Abstract

Spleen tyrosine kinase (Syk) has been implicated in a number of pathologies including cancer and rheumatoid arthritis and thus has been pursued as a novel therapeutic target. Because of the complex relationship between Syk's auto- and other internal phosphorylation sites, scaffolding proteins, enzymatic activation state and sites of phosphorylation on its known substrates, the role of Syk's activity in these diseases has not been completely clear. To approach such analyses, we developed a Syk-specific artificial peptide biosensor (SAStide) to use in a cell-based assay for direct detection of intracellular Syk activity and inhibition in response to physiologically relevant stimuli in both laboratory cell lines and primary splenic B cells. This peptide contains a sequence derived from known Syk substrate preference motifs linked to a cell permeable peptide, resulting in a biosensor that is phosphorylated in live cells in a Syk-dependent manner, thus serving as a reporter of Syk catalytic activity in intact cells. Because the assay is compatible with live, primary cells and can report pharmacodynamics for drug action on an intended target, this methodology could be used to facilitate a better understanding of Syk's function and the effect of its inhibition in disease.

Indexed as

Biosensing TechniquesAnimalsB-LymphocytesCell LineEnzyme ActivationEnzyme-Linked Immunosorbent AssayIntracellular Signaling Peptides and ProteinsMicePeptidesPhosphorylationProtein-Tyrosine KinasesSpectrometry, FluorescenceSyk KinaseIntracellular Signaling Peptides and ProteinsPeptidesProtein-Tyrosine KinasesSyk KinaseSyk protein, mouse

Identifiers

PMID22920457
PMCPMC3545090
OpenAlexW1977263641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.